|
1
|
Haq SU, Symeon C, Agius M and Brady R:
Screening for depression in post stroke patients. Psychiatr Danub.
22:33–35. 2010.PubMed/NCBI
|
|
2
|
Mihara T, Mihara K, Yarimizu J, et al:
Pharmacological characterization of a novel, potent adenosine A1
and A2 receptor dual antagonist,
5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one(ASP5854),
in models of Parkinson’s disease and cognition. J Pharmacol Exp
Ther. 323:708–719. 2007.PubMed/NCBI
|
|
3
|
Barba R, Martínez-Espinosa S,
Rodríguez-García E, Pondal M, Vivancos J and Del Ser T: Post-stroke
dementia: clinical features and risk factors. Stroke. 31:1494–1501.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Erickson KI, Prakash RS, Voss MW, et al:
Brain-derived neurotrophic factor is associated with age-related
decline in hippocampal volume. J Neurosci. 30:5368–5375.
2010.PubMed/NCBI
|
|
5
|
Li G, Peskind ER, Millard SP, et al:
Cerebrospinal fluid concentration of brain-derived neurotrophic
factor and cognitive function in non-demented subjects. PLoS One.
4:e54242009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
O’Bryant SE, Hobson VL, Hall JR, et al:
Serum brain-derived neurotrophic factor levels are specifically
associated with memory performance among Alzheimer’s disease cases.
Dement Geriatr Cogn Disord. 31:31–6. 2011.PubMed/NCBI
|
|
7
|
von Bohlen und Halbach O: Involvement of
BDNF in age-dependent alterations in the hippocampus. Front Aging
Neurosci. 13:22010.PubMed/NCBI
|
|
8
|
Zhou Z, Lu T, Xu G, et al: Decreased serum
brain-derived neurotrophic factor (BDNF) is associated with
post-stroke depression but not with BDNF gene Val66Met
polymorphism. Clin Chem Lab Med. 49:185–189. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang L, Zhang Z, Sun D, et al: Low serum
BDNF may indicate the development of PSD in patients with acute
ischemic stroke. Int J Geriatr Psychiatry. 26:495–502. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Teixeira AL, Barbosa IG, Diniz BS and
Kummer A: Circulating levels of brain-derived neurotrophic factor:
correlation with mood, cognition and motor function. Biomark Med.
4:871–887. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Murer M, Yan Q and Raisman-Vozari R:
Brain-derived neurotrophic factor in the control human brain, and
in Alzheimer’s disease and Parkinson’s disease. Prog Neurobiol.
63:71–124. 2001.
|
|
12
|
McAllister AK: Neurotrophins and neuronal
differentiation in the central nervous system. Cell Mol Life Sci.
58:1054–1060. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mertz K, Koscheck T and Schilling K:
Brain-derived neurotrophic factor modulates dendritic morphology of
cerebellar basket and stellate cells: an in vitro study.
Neuroscience. 97:303–310. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ohira K and Hayashi M: A new aspect of the
TrkB signaling pathway in neural plasticity. Curr Neuropharmacol.
7:276–285. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yoshii A and Constantine-Paton M:
Post-synaptic BDNF-TrkB signaling in synapse maturation, plasticity
and disease. Dev Neurobiol. 70:304–322. 2010.PubMed/NCBI
|
|
16
|
Figurov A, Pozzo-Miller LD, Olafsson P,
Wang T and Lu B: Regulation of synaptic responses to high frequency
stimulation and LTP by neurotrophins in the hippocampus. Nature.
381:706–709. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cunha C, Brambilla R and Thomas KL: A
simple role for BDNF in learning and memory? Front Mol Neurosci.
3:12010.PubMed/NCBI
|
|
18
|
Angelucci F, Mathé AA and Aloe L:
Neurotrophic factors and CNS disorders: findings in rodent models
of depression and schizophrenia. Prog Brain Res. 146:151–165. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Almeida RD, Manadas BJ, Melo CV, et al:
Neuroprotection by BDNF against glutamate-induced apoptotic cell
death is mediated by ERK and PI3-kinase pathways. Cell Death
Differ. 12:1329–1343. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Harper MM, Adamson L, Blits B, Bunge MB,
Grozdanic SD and Sakaguchi DS: Brain-derived neurotrophic factor
released from engineered mesenchymal stem cells attenuates
glutamate- and hydrogen peroxide-mediated death of
staurosporine-differentiated RGC-5 cells. Exp Eye Res. 89:538–548.
2009. View Article : Google Scholar
|
|
21
|
Longa EZ, Weinstein PR, Carlson S and
Cummins R: Reversible middle cerebral artery occlusion without
craniectomy in rats. Stroke. 20:84–91. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu J, Zhang QG, Li C and Zhang GY:
Subtoxic N-methyl-D-aspartate delayed neuronal death in ischemic
brain injury through TrkB receptor- and calmodulin-mediated
PI-3K/Akt pathway activation. Hippocampus. 14:525–537. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tata DA, Marciano VA and Anderson BJ:
Synapse loss from chronically elevated glucocorticoids:
relationship to neuropil volume and cell number in hippocampal area
CA3. J Comp Neurol. 498:363–374. 2006.PubMed/NCBI
|
|
24
|
Jacobsen JP and Mørk A: Chronic
corticosterone decreases brain-derived neurotrophic factor (BDNF)
mRNA and protein in the hippocampus, but not in the frontal cortex,
of the rat. Brain Res. 110:221–225. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Numakawa T, Kumamaru E, Adachi N, Yagasaki
Y, Izumi A and Kunugi H: Glucocorticoid receptor interaction with
TrkB promotes BDNF-triggered PLC-gamma signaling for glutamate
release via a glutamate transporter. Proc Natl Acad Sci USA.
106:647–652. 2009. View Article : Google Scholar : PubMed/NCBI
|
